FDA’s Center for Drug Evaluation and Research Releases Statement on New Opioid Analgesic Labeling Changes
Douglas Throckmorton, M.D., releases statement on behalf of FDA addressing changes to new opioid analgesic labeling.
Douglas Throckmorton, M.D., releases statement on behalf of FDA addressing changes to new opioid analgesic labeling.
